Health Robotics Announces New York and Texas Pharmacy Events, Including Competitors’ Comparisons

Bozen, Sud-Tirol, Italy – February 4th, 2014

Health Robotics announced its upcoming schedule for additional regional events, [http://www.health-robotics.com/en/about-health-robotics/events/] inviting interested pharmacy professionals to visit the company’s Second Generation solutions at symposia in Albany [NY] and Houston [TX], to network with their peers and Health Robotics’ distributor’s personnel at the New York Pharmacy Technology Summit [March 21], and the Texas Society of Health-System Pharmacists [April 11-12], including setting up site visits to hospital peers utilizing Health Robotics’ solutions.

Gaspar DeViedma, Health Robotics’ Executive Vice President, stated: “As we started supporting regional events in 2013 with the California Society of Health- System Pharmacists, we are continuing on this path in 2014, showcasing New York’s new installations at Albany Medical Center, Maimonides Medical Center, University of Rochester Medical Center, and Texas’ Michael DeBakey Veterans Administration Medical Center, where Health-System pharmacists can compare and contrast Health Robotics’ world leading solutions, without the hype routinely uttered by its global competitors1, whose bids were rejected by these institutions.”.

At the New York Pharmacy Technology Summit in Albany, Health Robotics’ customers’ William Churchill from Brigham and Women’s Hospital in Boston, and Dave Webster from University of Rochester Medical Center are scheduled to offer their expert opinions during keynote presentations and follow-up panel discussions.

Mr. DeViedma continued: “One competitor (Intelligent Hospital Systems-RIVA) routinely claims to be the only robot with “true walk-away capabilities”, which is utter nonsense considering that even old IV Robots have had this feature for decades. In my opinion, this hype only demonstrates that it takes RIVA’s users so long to load and so long to process IV doses that they truly have to “walk away” and come back several hours later or even the next day in order to retrieve the IV output. This IHS “unattended” claim is also counterintuitive to the same company’s claim that it takes 1.5 FTEs to support RIVA. What are the 1.5 RIVA FTEs necessary for, if this is true? Similarly, another competitor (APOTECAchemo) routine propaganda was widely exposed2 for its ongoing problems at the November 15th edition of the American Journal of Health System Pharmacy.”